28 results
6-K
EX-99.1
LSB
LakeShore Biopharma Co., Ltd
15 Aug 24
LakeShore Biopharma Announces Financial Results for Fiscal Year 2024
8:40am
operations
Other income (expenses):
Late fees for taxes other than income tax
Late fees for social security insurance
Government grants
Financial expenses
424B3
LSB
LakeShore Biopharma Co., Ltd
8 May 24
Prospectus supplement
8:32am
and administrative
Research and development
Total operating expenses
Loss from operations
Other income (expenses):
Late fees for social security insurance
6-K
EX-99.1
jxqpue9pm4
19 Apr 24
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024
8:03am
POS AM
bd93u78 he1xq
23 Jan 24
Prospectus update (post-effective amendment)
4:18pm
6-K
EX-99.1
7nf7om0
22 Jan 24
YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024
5:10pm
424B3
cu64w6z 681b1zvm
25 Sep 23
Prospectus supplement
6:07am
6-K
EX-99.1
e4x 4e328
16 Aug 23
YS Biopharma Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2024
8:00am
424B3
llrd3zf5krfvr5c
15 Aug 23
Prospectus supplement
8:00am
POS AM
iz8g55za
8 Aug 23
Prospectus update (post-effective amendment)
4:06pm
20-F
lh7g7m
26 Jul 23
Annual report (foreign)
4:02pm
424B3
gqjk9eewkh q8viixpm
5 Jun 23
Prospectus supplement
4:03pm
F-1/A
15xt5db5
12 May 23
Registration statement (foreign) (amended)
4:05pm
6-K
EX-99.1
8f0a3kq3aakiuyq0
18 Apr 23
YS Biopharma Announces Record Vaccine Revenues and Preliminary
8:00am
F-1
yuy65n08kx6mdag
12 Apr 23
Registration statement (foreign)
8:49am
F-4
EX-99.2
tvh4o94 1v4x4k
28 Dec 22
Registration of securities (foreign)
6:58am
F-4
EX-10.12
dq2zxpadvhnc
28 Dec 22
Registration of securities (foreign)
6:58am
F-4
f7jkm4w
28 Dec 22
Registration of securities (foreign)
6:58am